Navigation Links
AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
Date:2/19/2008

QUEBEC CITY, Feb. 19 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, David J. Mazzo, Ph.D., will present a company overview at the Roth Capital Partners 20th Annual OC Growth Stock Conference on February 20, 2008 at 4:00 pm PT, in the Ballroom of the Ritz Carlton Laguna Niguel in Dana Point, California.

A live webcast of this presentation will be available on AEterna Zentaris' website at http://www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at http://www.aezsinc.com.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
2. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
7. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
8. PLC Systems to Present at the ROTH Conference
9. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
10. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
11. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Cambrian ... for industrial facilities, today announced that one of the nation’s fastest growing craft ... novel water-energy purchase agreement (WEPA). Under the WEPA, a first for the industrial ...
(Date:12/6/2016)... -- The American Botanical Council (ABC) recognizes wellness ... Arnica montana ) through ABC,s Adopt-an-Herb program. This ... database, a comprehensive, interactive online tool that provides ... on the uses and health effects of more ... wellness company with healing arts centers, skin and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... automation and IT solutions, today announced the company has successfully completed its 50th ... executed automation and control systems integration services to leading companies in life sciences, ...
(Date:12/6/2016)... Zimmer Biomet Holdings, Inc. (NYSE and ... terms of its previously-announced cash tender offers (the ... (excluding accrued and unpaid interest to, but not ... and expenses related to the Offers) (the "Maximum ... the table below (collectively, the "Notes"). The terms ...
Breaking Biology Technology:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/17/2016)... Calif. , Nov. 17, 2016  AIC announces that it has just released ... in organizations that require high-performance scale-out plus high speed data transfer storage solutions. ... ... ... Setting up a high ...
(Date:11/15/2016)... Nov. 15, 2016  Synthetic Biologics, Inc. (NYSE ... focused on the gut microbiome, today announced the ... shares of its common stock and warrants to ... a price to the public of $1.00 per ... Biologics from the offering, excluding the proceeds, if ...
Breaking Biology News(10 mins):